drugset / Trial / NCT02817243
The DDI Study of SP2086 and Simvastatin
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to investigate the potential interaction between multiple oral doses of SP2086 and a single oral dose of Simvastatin in healthy adult volunteers.
Timeline
- Start
- 2016-03
- Primary completion
- 2016-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Retagliptin | Small molecule | 100 mg | Oral |
| Subject | Simvastatin | Small molecule | 40 mg | Oral |